Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.2K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.2K
Activation of Integrins01:15

Activation of Integrins

4.5K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
4.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.4K
Integrins01:10

Integrins

4.8K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.8K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

6.2K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.3K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2-Amino-3,4-Dihydroquinazolines Exhibit Potent Antimalarial Activity by Targeting Plasmepsin X.

ACS infectious diseases·2026
Same author

Gelatin methacryloyl hydrogel with post-injection magnetic alignment: Structural modulation and protein-cell interactions.

Colloids and surfaces. B, Biointerfaces·2026
Same author

A 3D-Printed Scaffolded Hydrogel Microneedle Array Biosensor for Real-Time, Continuous Monitoring.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Drug Screening of Sarcoma Cells: Finding Shared Sensitivities.

Cancer research communications·2026
Same author

Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer.

bioRxiv : the preprint server for biology·2026
Same author

Ex vivo effects of low dose delayed release rapamycin on agonist-induced platelet aggregation, activation and procoagulant platelet phenotypes in domestic cats.

Scientific reports·2026

Related Experiment Video

Updated: Nov 20, 2025

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
04:15

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

2.1K

Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk.

Deenadayalan Bakthavatsalam1, John W Craft1,2, Anna Kazansky1

  • 1Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, TX, United States.

Frontiers in Immunology
|January 25, 2021
PubMed
Summary

Novel beta-lactam antibiotics, cefsulodin and ceftazidime, inhibit spleen tyrosine kinase (Syk) and integrin interactions. This approach targets inflammation by blocking specific Syk signaling pathways without affecting other critical immune functions.

Keywords:
cell adhesionhigh-throughput screeningimmune response receptorinflammationintegrinsignalingtyrosine kinaseβ-lactam antibiotics

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.3K
Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
09:14

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes

Published on: June 13, 2014

16.5K

Related Experiment Videos

Last Updated: Nov 20, 2025

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
04:15

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

2.1K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.3K
Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
09:14

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes

Published on: June 13, 2014

16.5K

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Leukocyte inflammatory responses depend on spleen tyrosine kinase (Syk) signaling.
  • Syk is activated through interactions with integrin cell-adhesion molecules.
  • Targeting Syk is crucial for managing inflammatory conditions.

Purpose of the Study:

  • To identify small molecules inhibiting Syk-integrin cytoplasmic domain interactions.
  • To explore a novel therapeutic strategy for inflammation by modulating Syk signaling.

Main Methods:

  • Developed a high-throughput screen to identify Syk-integrin inhibitors.
  • Screened compound libraries, including beta-lactam antibiotics.
  • Utilized molecular modeling to understand inhibitor binding.
  • Assessed the impact of inhibitors on integrin signaling and cytokine production.

Main Results:

  • Identified cefsulodin and ceftazidime as inhibitors of Syk-integrin binding (IC50 range, 1.02-4.9 µM).
  • Demonstrated that ceftazidime inhibits adhesion-dependent upregulation of IL-1β and MCP-1 via Syk.
  • Showed that these compounds inhibit Syk without affecting FcγRI-mediated ITAM-dependent phosphorylation.
  • Confirmed novel binding sites for inhibitors outside the Syk kinase and pITAM domains.

Conclusions:

  • Ceftsulodin and ceftazidime offer a novel method to target Syk-integrin signaling.
  • This approach selectively abrogates integrin-mediated Syk signaling while preserving ITAM-dependent pathways.
  • This represents a promising strategy for developing new anti-inflammatory therapies.